Home/Filings/4/0000950170-24-010601
4//SEC Filing

Marango Jotin 4

Accession 0000950170-24-010601

CIK 0001835579other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:08 PM ET

Size

5.3 KB

Accession

0000950170-24-010601

Insider Transaction Report

Form 4
Period: 2024-02-01
Marango Jotin
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-01+181,000181,000 total
    Exercise: $1.36Exp: 2034-02-01Common Stock (181,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on January 1, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Documents

1 file

Issuer

Ikena Oncology, Inc.

CIK 0001835579

Entity typeother

Related Parties

1
  • filerCIK 0001777513

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:08 PM ET
Size
5.3 KB